showed that partial M-HIFU ablation in a more immunogenic neuroblastoma tumor model synergized with checkpoint inhibitors (anti-PD-L1 plus anti-CTLA4) and significantly prolonged survival (36). Here, CTLA4 is linked to neuroblastoma.